Residual disease activity and treatment adjustments in psoriatic arthritis in current clinical practice

by Leonieke J. J. van Mens, Marleen G. H. van de Sande, Inka A. Fluri, Sadaf Atiqi, Arno W. R. van Kuijk, Dominique L. P. Baeten
Published 2017-10-01

IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt

by Renée H. Fiechter, Renée H. Fiechter, Renée H. Fiechter, Henriëtte M. de Jong, Henriëtte M. de Jong, Henriëtte M. de Jong, Leonieke J. J. van Mens, Leonieke J. J. van Mens, Leonieke J. J. van Mens, Inka A. Fluri, Inka A. Fluri, Inka A. Fluri, Sander W. Tas, Sander W. Tas, Sander W. Tas, Dominique L. P. Baeten, Dominique L. P. Baeten, Dominique L. P. Baeten, Nataliya G. Yeremenko, Nataliya G. Yeremenko, Nataliya G. Yeremenko, Marleen G. H. van de Sande, Marleen G. H. van de Sande, Marleen G. H. van de Sande
Published 2021-03-01

Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension...

by Henriëtte M. Y. de Jong, Leonieke J. J. van Mens, Michael T. Nurmohamed, Marc R. Kok, Arno W. R. van Kuijk, Dominique L. P. Baeten, Marleen G. H. van de Sande
Published 2019-09-01